Beam Therapeutics Inc.

BEAM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$24.95+1.13%

2026-09-18

Financials

Valuation Metrics

Beam Therapeutics Inc.'s Market Cap is $2.57B. At end of 2025 it was $2.85B. Ranked #1858 of 3,121 in US market (top 60%), #684 of 1,463 on NASDAQ (top 47%), #115 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 43%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$2.57B	US#1,858/3,121 Sec#115/266
Revenue	$156M	US#2,627/3,121 Sec#116/266
Net Income	$-85M	US—/3,121 Sec—/266
Total Assets	$1.39B	US#2,308/3,121 Sec#73/266
Net Assets	$1.07B	US#1,724/3,121 Sec#61/266
Value
P/B	2.40x	US#1,474/3,121 Sec#65/266
P/S	16.45x	US#2,816/3,121 Sec#137/266
FCF Yield	-9.43%	US—/3,121 Sec—/266
Profitability
ROE	-8.00%	US#2,330/3,121 Sec#78/266
ROA	-6.16%	US#2,575/3,121 Sec#91/266
Op. Margin	-242.27%	US#2,783/3,121 Sec#142/266
Revenue Growth	158.88%	US#67/3,121 Sec#24/266
Financial Health
Debt Ratio	29.90%	US#335/3,121 Sec#105/266
Total Debt	$247M	US#2,183/3,121 Sec#90/266
FCF	$-242M	US#2,815/3,121 Sec#223/266
Cash	$220M	US#1,658/3,121 Sec#102/266
Current Ratio	14.57x	US#175/3,121 Sec#53/266
Performance
1Y Return	-0.60%	US#1,467/3,121 Sec#169/266
1M Return	-14.17%	US#2,080/3,121 Sec#159/266
From 52W High	-34.79%	US#2,325/3,121 Sec#178/266
1Y MDD	-39.08%	US#1,968/3,121 Sec#136/266
Trading
Volume	2,121,002 shares	US#724/3,121 Sec#72/266
Trading Value	$53M	US#1,154/3,121 Sec#86/266
Per Share
EPS	$-0.83	US—/3,121 Sec—/266
BPS	$10.38	US#1,821/3,121 Sec#70/266